VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $0 | – | 0 | – | 0.00% | – |
| Q1 2021 | $0 | – | 0 | – | 0.00% | – |
| Q4 2020 | $0 | – | 0 | – | 0.00% | – |
| Q3 2020 | $0 | – | 0 | – | 0.00% | – |
| Q2 2020 | $0 | – | 0 | – | 0.00% | – |
| Q1 2020 | $0 | -100.0% | 0 | -100.0% | 0.00% | -100.0% |
| Q2 2018 | $688,000 | +42.1% | 29,618 | +27.2% | 0.03% | +31.8% |
| Q1 2018 | $484,000 | 0.0% | 23,277 | 0.0% | 0.02% | 0.0% |
| Q4 2017 | $484,000 | -73.6% | 23,277 | -81.8% | 0.02% | -69.9% |
| Q3 2017 | $1,836,000 | -17.3% | 128,095 | -0.2% | 0.07% | -22.3% |
| Q2 2017 | $2,220,000 | +57.4% | 128,305 | +0.4% | 0.09% | +54.1% |
| Q1 2017 | $1,410,000 | -16.0% | 127,796 | +10.6% | 0.06% | -24.7% |
| Q4 2016 | $1,678,000 | -60.6% | 115,556 | -33.4% | 0.08% | -63.5% |
| Q3 2016 | $4,262,000 | +22.9% | 173,588 | +0.8% | 0.22% | +14.4% |
| Q2 2016 | $3,467,000 | -77.6% | 172,134 | +12.8% | 0.19% | -81.4% |
| Q4 2015 | $15,509,000 | – | 152,572 | – | 1.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACCIPITER CAPITAL MANAGEMENT, LLC | 2,106,379 | $55,398,000 | 31.67% |
| Claren Road Asset Management, LLC | 80,000 | $2,820,000 | 24.27% |
| Okumus Fund Management Ltd. | 3,722,464 | $97,901,000 | 15.82% |
| Wingspan Investment Management, LP | 852,900 | $22,431,000 | 12.66% |
| FARLEY CAPITAL L.P. | 307,458 | $8,086,000 | 11.46% |
| Chou Associates Management | 976,843 | $25,725,000 | 8.35% |
| Wingspan Investment Management, LP | 550,700 | $14,483,000 | 8.17% |
| HAP Trading, LLC | 4,043,900 | $109,610,000 | 8.00% |
| LeVasseur Capital Partners LLC | 128,269 | $3,373,000 | 6.97% |
| Pershing Square Capital Management | 21,591,122 | $567,847,000 | 6.41% |